Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Robert S. Busch & Michael P. Kane. (2017) Combination SGLT2 inhibitor and GLP-1 receptor agonist therapy: a complementary approach to the treatment of type 2 diabetes. Postgraduate Medicine 129:7, pages 686-697.
Read now
Read now
Articles from other publishers (4)
Tevfik Demir, Serap Turan, Kursad Unluhizarci, Oya Topaloglu, Tufan Tukek & Dilek Gogas Yavuz. (2021) Use of Insulin Degludec/Insulin Aspart in the Management of Diabetes Mellitus: Expert Panel Recommendations on Appropriate Practice Patterns. Frontiers in Endocrinology 12.
Crossref
Crossref
Duygu Kes & Feray Gökdoğan. (2020) Relationship between medication adherence and psychosocial adjustment in patients with type 2 diabetes: A cross-sectional study. Nordic Journal of Nursing Research 40:3, pages 116-122.
Crossref
Crossref
Olesya Y. Gurova, Valentin V. Fadeev & Ekaterina S. Maloletkina. (2019) Injectable therapy in type 2 diabetes mellitus: strategies to improve therapeutic adherence. Diabetes mellitus 21:6, pages 524-533.
Crossref
Crossref
Laura Staun Valentiner, Ida Kær Thorsen, Malte Bue Kongstad, Cecilie Fau Brinkløv, Rasmus Tolstrup Larsen, Kristian Karstoft, Jens Steen Nielsen, Bente Klarlund Pedersen, Henning Langberg & Mathias Ried-Larsen. (2019) Effect of ecological momentary assessment, goal-setting and personalized phone-calls on adherence to interval walking training using the InterWalk application among patients with type 2 diabetes—A pilot randomized controlled trial. PLOS ONE 14:1, pages e0208181.
Crossref
Crossref